The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer-Reference-Cited by-同舟云学术

The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer

Published:2011-08-31 Issue:7 Volume:118 Page:1764-1773
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kim Tae Hyuk,Park Young Joo,Lim Jung Ah,Ahn Hwa Young,Lee Eun Kyung,Lee You Jin,Kim Kyung Won,Hahn Seo Kyung,Youn Yeo Kyu,Kim Kwang Hyun,Cho Bo Youn,Park Do Joon

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005;Chen;Cancer,2009

2. Thyroid cancer epidemiology and prognostic variables;Sipos;Clin Oncol (R Coll Radiol),2010

3. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients;Loh;J Clin Endocrinol Metab,1997

4. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer;Mazzaferri;Am J Med,1994

Cited by 353 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma;The Journal of Clinical Endocrinology & Metabolism;2024-08-01

2. Modified TI-RADS Coupled with BRAFV600E Enhances Diagnostic Efficiency in Papillary Thyroid Carcinoma: Prospective Study;International Journal of General Medicine;2024-07

3. Thyroid Nodules: Past, Present, and Future;Endocrine Practice;2024-06

4. Diagnostic value of FNAC combined with BRAFV600E mutation detection in Hashimoto’s thyroiditis complicated with papillary thyroid carcinoma;Frontiers in Endocrinology;2024-05-16

5. BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients;Oral Oncology;2024-05